Walking Program for Children Aged 9 to 12 with Phenylketonuria and Non-Alcoholic Fatty Liver Disease to Improve Liver Enzymes
Led by Cairo University · Updated on 2024-12-05
40
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Phenylketonuria PKU is an inherited disorder that raises phenylalanine levels in the blood and is linked with metabolic complications such as non-alcoholic fatty liver disease. Researchers are studying children with PKU and fatty liver disease to understand how a walking program might affect their liver health. This study is interventional and involves children aged 9 to 12 years who have PKU and fatty liver disease.
Participants will be randomly assigned to one of two groups. Group I will take part in a daily online supervised walking program for eight weeks. Group II will be a waitlisted control group that does not perform the walking program during this period. The program is designed to evaluate the response of liver enzymes after the intervention.
During the study, researchers will assess liver enzymes including alanine transaminase, aspartate transaminase, gamma-glutamyl transferase, and alkaline phosphatase, as well as triglycerides and body mass index after eight weeks. The study includes safety monitoring and data collection throughout the eight-week period. Total participation duration aligns with the length of the walking program and follow-up assessments.
CONDITIONS
Brief Title
Walking Program in Fatty Liver Children With Phenylketonuria
Research Team
A
Ali Isamil, Lecturer
S
shimaaa bondok, PHD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Outpatient Treatment
Duration - 8 weeks
Participants in the walking program group perform daily supervised walking online for eight weeks, while waitlisted participants do not receive the intervention during this time.
Daily online supervised walking sessions for 8 weeks
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Open-Label Study Evaluating NGGT002 Gene Therapy for Adults With Classic Phenylketonuria
Psychological Skills Program and New Assessment Tools for Anxiety and Depression in Adolescents with Phenylketonuria PKU
Study of Endoscopic Sleeve Gastroplasty Plus Lifestyle Changes Versus Lifestyle Changes Alone in Adults With Obesity and Metabolic Dysfunction-Associated Steatohepatitis
Evaluating Safety and Effectiveness of Large Neutral Amino Acids for Adults with Classical Phenylketonuria
Exercise Impact on Metabolic Syndrome and Fatty Liver in Female Adolescents with Celiac Disease
Study of Metabolic Control and Quality of Life in Phenylketonuria Patients Aged 10 Years and Older Receiving Dietary or Drug Treatment
Effects of Palynziq Treatment on Diet, Brain Health, and Nutrition in Adults with Phenylketonuria PKU
Study Evaluating Intravenous NGGT002 Gene Therapy in Adults with Phenylketonuria
Walking Program for Children Aged 9 to 12 with Phenylketonuria and Non-Alcoholic Fatty Liver Disease to Improve Liver Enzymes